Feasibility of HLA-haploidentical hematopoietic stem cell transplantation between noninherited maternal antigen (NIMA)-mismatched family members linked with long-term fetomaternal microchimerism

Blood

Volumn 104, Issue 12, 2004, Pages 3821-3828

  Ichinohe, Tatsuo ^a   Uchiyama, Takashi ^b   Shimazaki, Chihiro ^b   Matsuo, Keitaro ^b   Tamaki, Shigehisa ^b   Hino, Masayuki ^b   Watanabe, Arata ^b   Hamaguchi, Motohiro ^b   Adachi, Souichi ^b   Gondo, Hisashi ^b   Uoshima, Nobuhiko ^b   Yoshihara, Takao ^b   Hatanaka, Kazuo ^b   Fujii, Hiroshi ^b   Kawa, Keisei ^b   Kawanishi, Kazunobu ^b   Oka, Koji ^b   Kimura, Hideo ^b   Itoh, Mitsuru ^b   Inukai, Takeshi ^b   Maruya, Etsuko ^b   Saji, Hiroh ^b   Kodera, Yoshihisa ^b   more..

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GRANULOCYTE COLONY STIMULATING FACTOR; HLA A ANTIGEN; HLA ANTIGEN; HLA ANTIGEN CLASS 2; HLA ANTIGEN CLASS 3; HLA B ANTIGEN; HLA DR ANTIGEN; INHERITED PATERNAL ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONINHERITED MATERNAL ANTIGEN; TACROLIMUS; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; CHILD; CHRONIC GRAFT REJECTION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DISEASE SEVERITY; FAMILIAL DISEASE; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HLA MISMATCH; HUMAN; LARGE CELL LYMPHOMA; LEUKOCYTE COUNT; LONG TERM CARE; MALE; MICROCHIMERISM; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; T CELL LEUKEMIA; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME;

EID: 8844285439     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-03-1212     Document Type: Article

References (58)

1. Rocha V, Wagner JE Jr, Sobocinski KA, et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med. 2000;342:1846-1854.
2. Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med. 2001;344:1815-1822.
3. Sanz GF, Saavedra S, Planelles D, et al. Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. Blood. 2001;98:2332-2338.
4. Ooi J, Iseki T, Takahashi S, et al. Unrelated cord blood transplantation for adult patients with advanced myelodysplastic syndrome. Blood. 2003;101:4711-4713.
5. Ooi J, Iseki T, Takahashi S, et al. Unrelated cord blood transplantation for adult patients with de novo acute myeloid leukemia. Blood. 2004:103;489-491.
6. Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, Miller JS, Wagner JE. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood. 2003;102:1915-1919.
7. Beatty PG, Clift RA, Mickelson EM, et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med. 1985;313:765-771.
8. Anasetti C, Amos D, Beatty PG, et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med. 1989;320:197-204.
9. Henslee-Downey PJ, Abhyankar SH, Parrish RS, et al. Use of partially mismatched related donors extends access to allogeneic marrow transplant. Blood. 1997;89:3864-3872.
10. Aversa F, Tabilio A, Velardi A, et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med. 1998;339:1186-1193.
11. Guinan EC, Boussiotis VA, Neuberg D, et al. Transplantation of anergic histoincompatible bone marrow allografts. N Engl J Med. 1999;340:1704-1714.
12. Claas FH, Roelen DL, Oudshoorn M, Doxiadis M. Future HLA matching strategies in clinical transplantation. Dev Ophthalmol. 2003;36:62-73.
13. Hendriks GF, D'Amaro J, Persijn GG, et al. Excellent outcome after transplantation of renal allografts from HLA-DRw6-positive donors even in HLA-DR mismatches. Lancet. 1983;2:187-189.
14. Maruya E, Takemoto S, Terasaki PI. HLA matching: identification of permissible HLA mismatches. Clin Transpl. 1993:511-520.
15. Claas FH, Gijbels Y, van der Velden-de Munck J, van Rood JJ. Induction of B cell unresponsiveness to noninherited maternal HLA antigens during fetal life. Science. 1988;241:1815-1817.
16. Burlingham WJ, Grauer AP, Heisey DM, et al. The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. N Engl J Med. 1998;339:1657-1664.
17. Smits JM, Claas FH, van Houwelingen HC, Persijn GG. Do noninherited maternal antigens (NIMA) enhance renal graft survival? Transpl Int. 1998;11:82-88.
18. van Rood JJ, Loberiza FR Jr, Znang MJ, et al. Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling. Blood. 2002;99:1572-1577.
19. Opelz G. Analysis of the "NIMA effect" in renal transplantation. Collaborative Transplant Study. Clin Transpl. 1990:63-67.
20. Pohanka E, Cohen N, Colombe BW, Lou C, Salvatierra O Jr, Garovoy MR. Non-inherited maternal HLA antigens and protection against sensitisation. Lancet. 1990;336:1025-1028.
21. Andrassy J, Kusaka S, Jankowska-Gan E, et al. Tolerance to noninherited maternal MHC antigens in mice. J Immunol. 2003;171:5554-5561.
22. Ichinohe T, Maruya E, Saji H. Long-term feto-maternal microchimerism: nature's hidden clue for alternative donor hematopoietic cell transplantation? Int J Hematol. 2002;76:229-237.
23. Tamaki S, Ichinohe T, Matsuo K, Hamajima N, Hirabayashi N, Dohy H. Superior survival of blood and marrow stem cell recipients given maternal grafts over recipients given paternal grafts. Bone Marrow Transplant. 2001;28:375-380.
24. Matsuo K, Hamajima N, Morishima Y, Harada M. Hospital capacity and post-transplant survival after allogeneic bone marrow transplantation: analysis of data from the Japan Society for Hematopoietic Cell Transplantation. Bone Marrow Transplant. 2000;26:1061-1067.
25. Ochiai N, Shimazaki C, Fuchida S, et al. Successful non-T cell-depleted HLA haplo-identical three-loci mismatched hematopoietic stem cell transplantation from mother to son based on the feto-maternal microchimerism in chronic myelogenous leukemia. Bone Marrow Transplant. 2002;30:793-796.
26. Shimazaki C, Ochiai N, Uchida R, et al. Non-T-cell-depleted HLA haploidentical stem cell transplantation in advanced hematologic malignancies based on the feto-maternal michrochimerism. Blood. 2003;101:3334-3336.
27. Umeda K, Adachi S, Ishihara H, et al. Successful T-cell-replete peripheral blood stem cell transplantation from HLA-haploidentical microchimeric mother to daughter with refractory acute lymphoblastic leukemia using reduced-intensity conditioning. Bone Marrow Transplant. 2003;31:1061-1063.
28. Uoshima N, Kamitsuji Y, Maruya E, Saji H. Successful reduced-intensity stem cell transplantation from an HLA haploidentical 3-loci-mismatched donor on the basis of fetomaternal microchimerism in a patient with advanced acute myeloid leukemia. Int J Hematol. 2003;78:69-72.
29. Ishida H, Morimoto A, Yoshihara T, et al. Non-T-cell-depleted HLA-haploidentical hematopoietic stem cell transplantation from a family donor based on fetomaternal microchimerism in pediatric hematologic malignancies. J Pediatr Hematol Oncol. 2004;26:68-71.
30. Marsh SG, Bodmer JG, Albert ED, et al. Nomenclature for factors of the HLA system, 2000. Tissue Antigens. 2001;57:236-283.
31. Tokita K, Terasaki P, Maruya E, Saji H. Tumour regression following stem cell infusion from daughter to microchimeric mother. Lancet. 2001;358:2047-2048.
32. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant. 1995;15:825-828.
33. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69:204-217.
34. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18:695-706.
35. Cox D. Regression models and life tables. J R Stat Soc Ser B. 1972;34:187-220.
36. Kato S, Yabe H, Yasui M, et al. Allogeneic hematopoietic transplantation of CD34+ selected cells from an HLA haplo-identical related donor. A long-term follow-up of 135 patients and a comparison of stem cell source between the bone marrow and the peripheral blood. Bone Marrow Transplant. 2000;26:1281-1290.
37. Kanda Y, Chiba S, Hirai H, et al. Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000). Blood. 2003;102:1541-1547.
38. Yamasaki S, Ohno Y, Taniguchi S, et al. Allogeneic peripheral blood stem cell transplantation from two- or three-loci-mismatched related donors in adult Japanese patients with high-risk hematologic malignancies. Bone Marrow Transplant. 2004;33:279-289.
39. Cairo MS, Wagner JE. Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. Blood. 1997;90:4665-4678.
40. van Kampen CA, Versteeg-van der Voort Maarschalk MF, Langerak-Langerak J, van Beelen E, Roelen DL, Claas FH. Pregnancy can induce long-persisting primed CTLs specific for inherited paternal HLA antigens. Hum Immunol. 2001;62:201-207.
41. Verdijk RM, Kloosterman A, Pool J, et al. Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: implications for stem cell transplantation and immunotherapy. Blood. 2004;103:1961-1964.
42. Harris DT, Schumacher MJ, LoCascio J, Booth A, Bard J, Boyse EA. Immunoreactivity of umbilical cord blood and post-partum maternal peripheral blood with regard to HLA-haploidentical transplantation. Bone Marrow Transplant. 1994;14:63-68.
43. Polchi P, Lucarelli G, Galimberti M, et al. Haploidentical bone marrow transplantation from mother to child with advanced leukemia. Bone Marrow Transplant. 1995;16:529-535.
44. Mellor AL, Munn DH. Immunology at the maternal-fetal interface: lessons for T cell tolerance and suppression. Annu Rev Immunol. 2000;18:367-391.
45. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol. 2004;5:266-271.
46. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A. 1996;93:705-708.
47. Maloney S, Smith A, Furst DE, et al. Microchimerism of maternal origin persists into adult life. J Clin Invest. 1999;104:41-47.
48. Adams KM, Nelson JL. Microchimerism: an investigative frontier in autoimmunity and transplantation. JAMA. 2004;291:1127-1131.
49. Saji H, Maruya E, Ichinohe T, Tamaki S, Watanabe A, Ogawa H. Long-term feto-maternal microchimerism: an indicator of HLA-haploidentical/mismatched donation. In: Hansen JA, Dupont B, eds. HLA 2004: Immunobiology of the Human MHC. Vol 2. Seattle, WA: IHWG Press. In press.
50. Adams KM, Lambert NC, Heimfeld S, et al. Male DNA in female donor apheresis and CD34-enriched products. Blood. 2003;102:3845-3847.
51. Anderson CC, Matzinger P. Immunity or tolerance: opposite outcomes of microchimerism from skin grafts. Nat Med. 2001;7:80-87.
52. Burlingham WJ, Grailer AP, Fechner JH Jr, et al. Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient. Transplantation. 1995;59:1147-1155.
53. Cai J, Lee J, Jankowska-Gan E, et al. Minor H antigen HA-1-specific regulator and effector CD8+ Tcells, and HA-1 microchimerism, inallograft tolerance. J Exp Med. 2004:199:1017-1023.
54. Hsu KC, Chida S, Geraghty DE, Dupont B. The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and alelic polymorphism. Immunol Rev. 2002;190:40-52.
55. Lin MT, Storer B, Martin PJ, et al. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hemato-poietic-cell transplantation. N Engl J Med. 2003;349:2201-2210.
56. Teshima T, Ordemann R, Reddy P, et al. Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat Med. 2002;8:575-581.
57. Mohty M, Kuentz M, Michallet M, et al. Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study. Blood. 2002;100:3128-3134.
58. Ringden O, Labopin M, Bacigalupo A, et al. Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia. J Clin Oncol. 2002;20:4655-4664.